S(+)-niguldipine
| SMILES | COC(=O)C1=C(C)NC(=C([C@H]1c1cccc(c1)[N+](=O)[O-])C(=O)OCCCN1CCC(CC1)(c1ccccc1)c1ccccc1)C |
| InChIKey | SVJMLYUFVDMUHP-XIFFEERXSA-N |
Chemical properties
| Hydrogen bond acceptors | 8 |
| Hydrogen bond donors | 1 |
| Rotatable bonds | 10 |
| Molecular weight (Da) | 609.3 |
Drug properties
| Molecular type | Small molecule |
| Physiological/Surrogate | Surrogate |
| Approved drug | Yes |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 9.1 | 9.5 | 9.9 | Guide to Pharmacology |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 6.3 | 7.0 | 7.7 | Guide to Pharmacology |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 5.9 | 6.65 | 7.4 | Guide to Pharmacology |
| α1A | ADA1A | Rat | Adrenoceptors | A | pKi | 9.3 | 9.3 | 9.3 | Guide to Pharmacology |
| α1A | ADA1A | Bovine | Adrenoceptors | A | pKi | 9.42 | 9.42 | 9.42 | ChEMBL |
| α1D | ADA1D | Rat | Adrenoceptors | A | pKi | 7.08 | 7.08 | 7.08 | ChEMBL |
| D5 | DRD5 | Human | Dopamine | A | pKi | 5.91 | 5.91 | 5.91 | ChEMBL |
| α1B | ADA1B | Rat | Adrenoceptors | A | pKi | 6.42 | 6.42 | 6.42 | ChEMBL |
| 5-HT1B | 5HT1B | Human | 5-Hydroxytryptamine | A | pKi | 6.44 | 6.44 | 6.44 | ChEMBL |
| α1B | ADA1B | Human | Adrenoceptors | A | pKi | 6.43 | 7.09 | 7.6 | ChEMBL |
| α1A | ADA1A | Rat | Adrenoceptors | A | pKi | 8.2 | 8.2 | 8.2 | ChEMBL |
| α1D | ADA1D | Human | Adrenoceptors | A | pKi | 6.72 | 6.86 | 7.0 | ChEMBL |
| α2B | ADA2B | Human | Adrenoceptors | A | pKi | 6.31 | 6.34 | 6.38 | ChEMBL |
| α2C | ADA2C | Human | Adrenoceptors | A | pKi | 6.43 | 6.47 | 6.49 | ChEMBL |
| M5 | ACM5 | Human | Acetylcholine (muscarinic) | A | pKi | 6.14 | 6.14 | 6.14 | ChEMBL |
| 5-HT7 | 5HT7R | Human | 5-Hydroxytryptamine | A | pKi | 6.5 | 6.5 | 6.5 | ChEMBL |
| D2 | DRD2 | Rat | Dopamine | A | pKi | 6.53 | 6.53 | 6.53 | ChEMBL |
| H1 | HRH1 | Human | Histamine | A | pKi | 7.05 | 7.05 | 7.05 | ChEMBL |
| α1A | ADA1A | Human | Adrenoceptors | A | pKi | 8.17 | 9.26 | 9.8 | ChEMBL |
| α2A | ADA2A | Human | Adrenoceptors | A | pKi | 5.64 | 6.04 | 6.28 | ChEMBL |
| M3 | ACM3 | Human | Acetylcholine (muscarinic) | A | pKi | 5.67 | 5.67 | 5.67 | ChEMBL |
| 5-HT6 | 5HT6R | Human | 5-Hydroxytryptamine | A | pKi | 6.06 | 6.06 | 6.06 | ChEMBL |
| D1 | DRD1 | Human | Dopamine | A | pKi | 6.43 | 6.43 | 6.43 | ChEMBL |
| H3 | HRH3 | Human | Histamine | A | pKi | 5.67 | 5.67 | 5.67 | ChEMBL |
| 5-HT2C | 5HT2C | Human | 5-Hydroxytryptamine | A | pKi | 5.73 | 5.73 | 5.73 | ChEMBL |
| δ | OPRD | Human | Opioid | A | pKi | 6.4 | 6.4 | 6.4 | ChEMBL |
| 5-HT1A | 5HT1A | Human | 5-Hydroxytryptamine | A | pKi | 6.27 | 6.27 | 6.27 | ChEMBL |
| A3 | AA3R | Human | Adenosine | A | pKi | 5.55 | 5.55 | 5.55 | ChEMBL |
| D3 | DRD3 | Human | Dopamine | A | pKi | 6.37 | 6.37 | 6.37 | ChEMBL |
| κ | OPRK | Human | Opioid | A | pKi | 6.46 | 6.46 | 6.46 | ChEMBL |
| μ | OPRM | Human | Opioid | A | pKi | 6.89 | 6.89 | 6.89 | ChEMBL |
| D2 | DRD2 | Human | Dopamine | A | pKi | 6.55 | 6.55 | 6.55 | ChEMBL |
| 5-HT5A | 5HT5A | Human | 5-Hydroxytryptamine | A | pKi | 6.37 | 6.37 | 6.37 | ChEMBL |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| GTP | Uniprot | Species | Family | Class | Type | Min | Avg | Max | Database |
| GPR183 | GP183 | Human | Orphan | A | pIC50 | 5.49 | 5.49 | 5.49 | ChEMBL |
| GPR35 | GPR35 | Human | Orphan | A | pIC50 | 5.43 | 5.43 | 5.43 | ChEMBL |
| FPR1 | FPR1 | Human | Formylpeptide | A | pIC50 | 5.42 | 5.42 | 5.42 | ChEMBL |
| GPR119 | GP119 | Human | GPR18, GPR55 and GPR119 | A | pIC50 | 5.46 | 5.46 | 5.46 | ChEMBL |
| S1P1 | S1PR1 | Human | Lysophospholipid (S1P) | A | pIC50 | 5.55 | 5.55 | 5.55 | ChEMBL |
| M2 | ACM2 | Human | Acetylcholine (muscarinic) | A | pIC50 | 5.36 | 5.36 | 5.36 | ChEMBL |
| apelin | APJ | Human | Apelin | A | pIC50 | 5.4 | 5.4 | 5.4 | ChEMBL |
| FPR3 | FPR3 | Human | Formylpeptide | A | pIC50 | 5.46 | 5.46 | 5.46 | ChEMBL |